Becoming a UWCCC Member
Procedure for UWCCC Membership Application
A request for UWCCC membership consideration must come from a UWCCC Program Leader. The Leader submits a letter of nomination to the UWCCC Director for consideration by the UWCCC Senior Leadership Committee. The nomination letter should describe the prospective member's qualifications to be a member of the Cancer Center and include a description of how the individual will contribute to the Leader's Program. The investigator's full curriculum vitae, including history of research funding, should be provided with the letter. A membership application form must also be completed.
Qualifications for Membership
Members are selected for their active participation in cancer research, their peer-reviewed research support and their personal commitment to involvement in the activities of the UWCCC, specifically their commitment to supporting collaborative research within the Cancer Center.
Member applications are prepared by the program leader and formally presented for review at monthly meetings of the UWCCC Senior Leadership Committee. A formal vote is taken and acceptance requires a majority approval. The new member receives a letter from the Director noting membership approval. The new member signs the letter to acknowledge his/her membership.
Arrangements should be made with the appropriate Program Leader for submission of the letter of nomination, curriculum vitae and completed membership application to Dr. Howard Bailey for membership consideration. Please contact Max Olin (608-890-3563) with questions.
|Scientific Program||Program Leaders|
|Cancer Prevention and Control (CPC)||Amy Trentham-Dietz, PhD and Hasan Mukhtar, PhD|
|Developmental Therapeutics (DT)||Glenn Liu, MD; Shigeki Miyamoto, PhD and Jing Zhang, PhD|
|Genetic and Epigenetic Mechanisms (GEM) (GN)||Emery Bresnick, PhD and Michael Newton, PhD|
|Human Cancer Virology (VR)||Paul Lambert, PhD and Shannon Kenney, MD|
|Imaging and Radiation Sciences (IR)||Mark Ritter, MD, PhD and Robert Jeraj, PhD|
|Tumor Microenvironment (TM)||Patricia Keely, PhD and David Beebe, PhD|